Pasco, Allyza .

HRN: 27-94-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2026
CEFTRIAXONE 1G (VIAL)
04/04/2026
04/10/2026
IV
700mg
Q24
AGE, URTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: